Battling triple-negative breast cancer

Two years ago, Brianna Hinojosa-Flores was a 41-year-old mother of two who had just been diagnosed with a cancer that’s tough to beat – triple-negative breast cancer. Today she’s back at work as an attorney, serves on her local City Council, enjoys time with her family, and shares her experience with other women who have been diagnosed with triple-negative breast cancer at an early age.

Triple-negative breast cancer is an aggressive type of cancer that does not respond to targeted drug therapies such as Tamoxifen, raloxifene (Evista), or Herceptin. It is associated with the BRCA gene and can affect women of any ethnicity, though it is more common in African-Americans. Women diagnosed with triple-negative breast cancer have a poorer short-term prognosis than those diagnosed with other breast cancer types.